MELBOURNE, Australia, Feb. 21, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey,.
MELBOURNE, Australia, Feb. 08, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore.
MELBOURNE, Australia, Nov. 28, 2023 (GLOBE NEWSWIRE) Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar “Coffee Microcaps Morning Meeting”, to be held on Thursday, 30th of November, 2023, 9:00am ADEST. CEO Steven Lydeamore will provide an overview and update on the business and upcoming milestones. Following the presentation, attendees will have the opportunity to ask q